Nadph P450 Reductase
Nadph P450 Reductase - Related Videos
01:28
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
0 Views •
2026
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
10:42
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
0 Views •
Cited by 16 •
2012
NADPH oxidase is the major source of reactive oxygen species (ROS) in phagocytes. Because of the ephemeral nature of ROS, it is difficult to measure and monitor ROS levels in living animals. A minimally invasive method for serial quantification of ROS in living mice is described.
01:27
Photosystem I
0 Views •
2019
Although structurally similar to photosystem II (PSII), photosystem I (PSI) is has a different electron supplier and electron acceptor. Both these photosystems work in concert. An excited electron from PSII is relayed to PSI via an electron transport chain in the thylakoid membrane of the chloroplast, which is comprised of the carrier molecule plastoquinone, the dual-protein cytochrome complex, and plastocyanin. As electrons move between PSII and PSI, they lose energy and must be re-energized...
03:47
Determination of ROS Production by Neutrophils upon Interaction with Opsonized Biofilm
0 Views •
2025
In this video, we demonstrate an in vitro chemiluminescence assay to detect the generation of reactive oxygen species by neutrophils upon exposure to an opsonized bacterial biofilm.
08:45
Isothermal Titration Calorimetry for Measuring Macromolecule-Ligand Affinity
0 Views •
Cited by 84 •
2011
A general protocol for the use of isothermal titration calorimetry to monitor the binding thermodynamics for biological systems with moderate binding affinities is presented.
FAQs
Electron flow proceeds in two linked transfers rather than as a single direct handoff. NADPH supplies the initial reducing input, which moves first through the reductase’s FAD cofactor and then through FMN to the partner cytochrome P450. This ordered pathway provides the electrons required for P450-dependent molecular oxygen activation, allowing substrate oxidation to proceed.
FAD and FMN contribute different stages of the same electron-transfer sequence. NADPH-derived reducing equivalents must pass through both cofactors in order, so disruption of either step can interrupt the supply needed by the associated P450 enzyme. This organization links reductase function directly to whether oxygen activation and substrate oxidation can occur.
Changes in reductase activity can shift the rate at which P450-dependent oxidation occurs. That shift may influence how quickly drugs are cleared and how compounds are biotransformed, thereby affecting pharmacological responses. Consequently, reductase status provides important context when interpreting variability in drug efficacy, toxicity, and metabolic behavior.
Researchers can examine the reductase together with cytochrome P450 rather than treating P450 oxidation as an isolated reaction. Following this partnership helps map how reducing equivalents support the conversion of a given drug, environmental chemical, or endogenous compound. The resulting pathway view can clarify metabolic fate and support interpretation of pharmacological effects.
The pathway is relevant to a broad set of substrates, including therapeutic drugs, environmental chemicals, and endogenous compounds. Studying these categories shows how the same electron-transfer partnership can influence different forms of oxidative metabolism. It also helps connect biochemical activity with practical outcomes such as clearance, efficacy, toxicity, and metabolic disposition.
Drug interactions can reflect changes in the P450-dependent oxidation of one or more compounds, and that oxidation depends on reductase-supported electron transfer. Altered reductase activity may therefore change the metabolic processing that underlies drug responses. Considering this partnership helps researchers interpret interactions alongside effects on clearance, efficacy, and toxicity rather than viewing each drug in isolation.